Skip to main content

Table 1 Summary of study and patient characteristics

From: RETRACTED ARTICLE: Comparison of bone morphogenetic protein and autologous grafting in the treatment of limb long bone nonunion: a systematic review and meta-analysis

Study

Study type

Country

Intervention

Case

Age, years

M/F

Nonunion time (months)

Follow-up (months)

Outcome

Cook [15]

RCT

USA

BMP

Autologous bone

14

16

23

7

27.2

> 9

(1), (2)

Chen et al. [19]

RCT

China

BMP + inorganic bone

Autologous bone

20

30

35

35

8.5

13.9 (8–60)

(1), (3)

Friedlaender et al. [16]

RCT

USA

BMP + autologous bone

Autologous bone

63

61

38

34

88

34

17

24

(1), (2), (5)

Zimmermann et al. [20]

n-RCT

Germany

BMP + autologous bone

Autologous bone

26

82

51

44

82

26

10

11

> 12

(1), (2) (5)

Tressler et al. [21]

n-RCT

USA

BMP

Autologous bone

19

74

45.11

41.69

57

36

> 6

20 ± 17.7

(1), (2)

von Ruden et al. [17]

RCT

Germany

BMP + autologous bone

Autologous bone

24

25

43

45

38

11

11

14 (6–8)

15 (6–54)

(1), (3)

Yin et al. [22]

n-RCT

China

BMP + autologous bone

Autologous bone

26

21

38

39

35

12

10–24

(1), (3), (4)

Hackl et al. [23]

n-RCT

Germany

BMP + autologous bone

Autologous bone

62

50

75

37

> 12

(1), (4)

 Humerus

   

13/9

49.0/51.0

13/9

14.8 ± 3.8

  

 Femoral

   

28/13

55.2/42.4

28/13

11.7 ± 1.1

  

 Tibia

   

21/28

51.6

42.3

34/15

10.3 ± 2.6

  

Liu et al. [18]

RCT

China

BMP + autologous bone

Autologous bone

22

20

42.25

41.57

26

16

6–24

(1), (3), (4), (5)

  1. RCT randomized controlled trial, n-RCT non-randomized controlled trial, BMP bone morphogenetic protein
  2. (1) Postoperative healing rate, (2) postoperative infection rate, (3) excellent and good rate of limb function, (4) the mean healing time, (5) secondary operation rate, (6) operation time, (7) intraoperative blood loss, (8) hospital stay, and (9) the hospitalization cost